Safety and pharmacokinetics of BAY 1817080, a P2X3 receptor antagonist, in healthy subjects: Results from a double-blind, randomised study

Category Primary study
ConferenceBritish Journal of Clinical Pharmacology
Year 2021
This article has no abstract
Epistemonikos ID: 0f41b714def702784aebc796579209f9f0c71a0b
First added on: Apr 30, 2026